Dr. Axelrod's clinical research focuses on the multidisciplinary management of thoracic and head and neck malignancies, emphasizing combined modality therapy and supportive care. She has co-authored several peer-reviewed publications on topics such as the use of immune checkpoint inhibitors in combination with radiotherapy for locally advanced squamous cell carcinoma of the head and neck, and the effects of preoperative programmed death-1 or programmed death ligand-1 inhibition on surgical complications in primary head and neck cancer .
Rita Axelrod, MD
Professor
Contact Information
Honickman Center
1101 Chestnut Street
14th Floor
Philadelphia, PA 19107
Professor
RESEARCH & CLINICAL INTEREST
Education
Medical School
New York University School of Medicine - 1970
Residency
Medical College of Georgia
Fellowship
Lankenau Hospital - 1976
Philadelphia General Hospital
Most Recent Peer-Reviewed Publications
- Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
- Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer
- In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
- Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1
Board Certifications
Internal Medicine
Medical Oncology
Hematology